Skip to main content

Free large sized intra-abdominal endometrioma in a postmenopausal woman: a case report



Endometriosis is an estrogen-dependent disease defined by the presence of endometrial glands and stroma out of the uterine cavity. Its prevalence is estimated to be 2–10% in reproductive aged women. Endometriosis occurrence is estimated to be 2.55% in postmenopausal patients due to the decreased levels of estrogen. Endometriosis can present in three different forms: superficial peritoneal implants, ovarian endometriomas, and deep infiltrating endometriosis. Ovarian endometriomas are the most common form of endometriosis. Even though endometriomas have been encountered in various localizations, a free abdominal endometrioma was only reported once in a premenopausal patient. Here, we are reporting the first case of a free large endometrioma in a postmenopausal patient.

Case presentation

A 67-year-old woman presented to the emergency department at our university hospital complaining of constipation and right flank pain. She suffered from uncontrolled primary hypertension and type 2 diabetes mellitus. On presentation, she was afebrile, hypertensive, and tachycardic. An abdominal CT scan revealed a large cystic mass measuring 17 × 26 cm in the anterior-posterior and transverse diameters respectively. The cyst caused bowel obstruction and right sided hydronephrosis. The patient underwent laparotomy and during the surgical exploration a large abdominal cyst adhered to the greater omentum was found. The cyst received plenteous blood supply from the greater omentum. The uterus and both ovaries were completely normal and didn’t have any connection to the cyst. An en-bloc cystectomy was performed successfully. The final histopathology report confirmed an abdominal endometrioma. The patient had an uneventful postoperative recovery.


Endometriomas might reach large sizes regardless of their location or the patient’s age. The close relation of free abdominal endometriomas with the greater omentum suggests that these were developed from endometriotic omental implants. Endometrioma is rare in postmenopausal women. However, it should be considered as a possible differential diagnosis at any age.

Peer Review reports


Endometriosis is a chronic inflammatory disease defined by the presence of endometrial glands and stroma out of the uterine cavity. Its prevalence is estimated to be 2–10% in reproductive aged women [1], and up to 50% in infertile women [2]. However, its prevalence decreases sharply in postmenopausal women to 2.55% [3]. Endometriosis can take one of either three forms: superficial peritoneal implants, ovarian endometriomas, and deep infiltrating endometriosis [4]. Ovarian endometriomas were found to be the most common form of endometriosis [5]. Extra-pelvic localizations of endometriomas, such as umbilical endometriomas (Villar’s node) are not rare and could be also encountered [6]. However, a free abdominal endometrioma was only reported once in a reproductive aged patient [7]. Endometriosis pathogenesis is controversial. Many hypotheses have been proposed but none of them explains precisely the origin of each of the three endometriosis forms. The retrograde menstruation is the most accepted hypothesis. It states that endometrial cells travel backwards with the menstrual blood along the fallopian tubes to seed within the peritoneal cavity [8]. Even though endometriosis is asymptomatic in the majority of cases [9], it may negatively affect the quality of life of patients and interfere with their daily life activities when symptoms occur [10]. Endometriosis can also provoke dyspareunia that leads to sexual dysfunction in 2–4% of sexually active women [11]. Moreover, Endometriosis was reported to be the most common cause of chronic pelvic pain in female patients [12]. Endometriosis is an estrogen-dependent disease [12]. Therefore, menopause often results in complete remission of the endometriotic lesions and associated symptoms [13]. In some cases, endometriosis can be reactivated by the increased estrogen production from peripheral organs or under the influence of the hormone replacement therapy (HRT) [14]. Rarely, endometriosis can relapse in postmenopausal women with normal estradiol serum levels [15]. This is mainly attributed to the endometriosis ability of biosynthesizing estrogen via the aromatase activity [12, 16]. Here, we are reporting the case of a postmenopausal patient that presented with free abdominal endometrioma measuring 45 cm in its largest diameter. The large endometrioma manifested clinically as a cyst causing abdominal distention and bowel obstruction. Interestingly, the patient didn’t have a history of endometriosis. To the best of our knowledge, this is the first case of a free endometrioma that reached such a large size in a postmenopausal woman.

Case presentation

A 67-year-old woman presented to the emergency department at our university hospital complaining of constipation and right flank pain. She suffered from uncontrolled hypertension and type 2 diabetes mellitus. Additionally, the patient claimed that she was diagnosed with an adnexal cyst 7 years ago. Her previous gynecologist did not manage to determine exactly whether the cyst was ovarian or abdominal in origin and no further surgical interventions or sonographic imaging follow-up were carried out. On presentation, the patient was hypertensive and tachycardic. She was afebrile and her oxygen saturation was normal. Upon clinical examination, her abdomen was distended and non-tender. Her cardiac auscultation revealed arrhythmic arrhythmia. The laboratory tests were unremarkable except for a raised blood glucose level of 201 mg/dL. Her complete blood count, electrolytes, liver and kidney function tests were within the normal limits. A 12-leads electrocardiogram revealed atrial fibrillation with rapid ventricular response. A computed tomography scan (CT scan) of the abdomen revealed the presence of a large multilocular cystic mass measuring 17 X 26 cm in its anterior-posterior and transverse diameters respectively. The cyst occupied most of the abdomen and caused bowel obstruction and right sided hydronephrosis (Fig. 1).

Fig. 1
figure 1

Computed tomography scan of the abdomen showing the homogenous cystic mass filled with isodense fluid. Note the presence of a right-sided hydronephrosis (yellow circle)

The initial differential diagnosis was either an omental cyst or abdominal abscess. The patient went preoperative optimization regarding the hypertension, hyperglycemia, and atrial fibrillation. The patient underwent a midline laparotomy. A large abdominal cyst adhered to the greater omentum was found. The cyst received its extensive vascular blood supply form the greater omentum (Fig. 2a). The uterus and both ovaries were unremarkable and were separate from the cyst. After ligating the cystic feeding vessels, an en-bloc cystectomy was performed successfully (Fig. 2b). Gross examination of the resected specimen revealed a large cystic mass measuring 45 cm in its longitudinal diameter and weighting 4.5 Kilograms. The cyst was multilocular and was filled primarily with clear fluid. Additionally, some cystic cavities were hemorrhagic.

Fig. 2
figure 2

The gross appearance of the abdominal endometrioma. Note the extensive omental blood supply to the cyst

Microscopic examination of the cyst revealed a columnar endometrial lining with underlying endometrial stroma and siderophages (Fig. 3). Based on the cyst’s characteristics, an abdominal endometrioma was diagnosed. The patient was hospitalized for 4 days and her postoperative recovery period was uneventful.

Fig. 3
figure 3

The microscopic appearance of the resected endometrioma stained in Hematoxylin & Eosin. Note the endometrial lining, endometrial stroma and siderophages

Discussion and conclusion

Endometriosis is known to be a disease of the reproductive age. This assumption may seem logic for the first instant regarding the substantial impact of estrogen on lesions’ progression. However, increasing data from the literature has shown that its occurrence in postmenopausal women is quiet possible. The most commonly seen form of endometriosis is ovarian endometriomas, also known as “chocolate cysts” [5]. Endometriomas form 27.2% of ovarian masses in women older than 40 years old, and only 4.3% of the ovarian pathologies in the sixth decade of life [17]. The relatively small number of endometriosis cases in postmenopausal women is primarily due to the diminished concentration of estrogen. After menopause, ovarian estrogen production declines significantly, which results in endometriosis remission in most patients [13]. However, endometriosis reactivation may result from the increased estrogen production from peripheral tissues –such as skin and fatty tissue- or by receiving HRT [14]. Nevertheless, endometriosis may present in the postmenopausal age without having a previous history of endometriosis. Regarding the remarkable percentage of asymptomatic cases, it’s unclear whether these lesions are undiagnosed premenopausal endometriosis or endometriosis originating in a postmenopausal age. The patient in this report did not receive HRT and unfortunately we did not measure her serum estradiol concentration to exclude the effect of endogenous estrogen. However, the presence of endometriosis in postmenopausal age without having previous HRT was reported in the literature [16]. This is mainly attributed to the endocrine intrinsic characteristics of endometriosis. Intrinsic signaling can make endometriotic cells function as independent unit. Ectopic endometrial cells can biosynthesize estrogen from cholesterol in the absence of any external substance, such as the adrenal androgens [12]. Endometriosis cells express a positive feedback loop that enhances the production of both estradiol E2 and prostaglandin E2 (PGE2) [12]. It is well established that PGE2 secreted from macrophages and ectopic endometrial cells stimulates the aromatase activity [18]. Estrogen in turn stimulates COX-2 enzyme to produce PGE2. It is estimated that retrograded endometrial cells duplicate the aromatase expression by 400 times [18, 19]. Apparently, the local estrogen production is as important as the circulating estrogen in fueling endometriosis. This is mainly evident in postmenopausal endometriotic patients with normal serum estrogen concentration [15]. Beside inducing ectopic endometrial cells proliferation, estrogen plays an important role in macrophage recruitment [20]. The recruited macrophages promote endometriosis progression and vascularization by secreting many growth factors, such as Transforming growth factor-β, Tumor necrosis factor-α, and Vascular endothelial growth factor (VEGF). It’s noteworthy that big amount of M2 macrophages was found within the endometriomas’ fluid in advanced stages of endometriosis. This finding attributes partially the fibrogenic effects of endometriosis to the activated M2 macrophages [21]. These may also contribute to the formation of the endometrioma’s fibrous wall. Moreover, growing evidence suggests that macrophages and other leukocytes secrete pro-inflammatory and adhesion molecules that alters the peritoneal environment. The aforementioned inflammatory changes provides better conditions for the differentiation, proliferation, adhesion and survival of the ectopic endometrial cells [22, 23]. The endometriotic cells also express VEGF intensively to maintain its vascularization [24]. It was postulated that the more endometriosis is well vascularized, the more active it becomes [25]. In fact, the plenteous blood supply that was provided by the omentum in our case and a previously reported one strongly support this postulation [7]. The extensive blood supply of the cyst may have contributed significantly to its massive enlargement. The exact formation mechanism of these cysts remains unknown. Some studies suggested the transformation of ovarian follicles and hemorrhagic corpora lutea into endometriomas [26, 27]. Nisolle et al. [4] suggested that endometriomas originate from the metaplastic transformation of the invaginated superficial ovarian coelomic epithelium. However, ovarian follicles and corpora lutea formation are directly linked to ovulation. The metaplastic transformation of the coelomic epithelium is achieved when it is exposed to estrogen concentration 10 times higher than the normal circulating estrogen level of the reproductive age [28]. Therefore, these mechanisms do not explain the endometrioma formation in our case. On the other hand, Brosens et al. [29] suggested that endometriomas are the result of adhesion formation between ovarian endometriotic implants, the peritoneum of the ovarian fossa and the broad ligament. This mechanism applies partly to our case because we believe that fibrogenesis around the endometrial cells within the omental substance is a substantial step in the pathogenesis of free abdominal endometriomas. The relation with the greater omentum may suggest a previous omental implantation of the endometriotic lesion, followed by the invasion of the submesothelial fatty tissue. The omentum can form a rich environment for endometriosis growth and progression. The omental fatty tissue provides the endometriotic cells directly with estrogen. We strongly suggest that free abdominal endometriomas are a special form of omental endometriosis. The low frequency of omental endometriosis –which is only 2%- may explain the rarity of this entity [30].

The preoperative diagnosis of endometriomas in unusual locations is challenging, especially when endometriomas reach large sizes. It is often confused with other neoplastic lesions that are more common in this group of patients, especially serous cystadenomas. These tumors are found to be the most common adnexal tumors in patients aged older than 60 years [17]. Different imaging modalities are useful to guide the pre-operative diagnosis. Endometrioma appearance on CT scan is nonspecific, and mimics many cystic masses. However, the presence of a central or peripheral hyper-dense focus within the cyst is a specific radiologic sign for endometriomas. Unfortunately, the sensitivity of this sign is estimated to be only 15% [31].

In reproductive aged women, endometriomas are usually treated by laparoscopic cystectomy. This approach carries a better pain relief and fertility outcomes compared to vaporizing the cystic cavity [32]. The recurrence rate after the cystectomy is estimated to be 10% [33]. Similarly, surgical resection of postmenopausal endometriosis remains the first line treatment. Unlike premenopausal endometriosis, postmenopausal endometriosis carries a higher risk of malignant transformation [34]. However, surgical interventions in patients older than 60 years often carry risks regarding the increased occurrence of chronic diseases. Therefore, alternative medical treatments should be considered. The third generation of aromatase inhibitors is highly recommended to treat postmenopausal endometriosis [35]. Administering letrozole or anastrozole for patients often resulted in symptoms relief within 4 to 15 months. Additionally, radiological regression of the disease was observed [34]. However, in these cases, endometriomas were generally small with good patients’ general condition. Often endometriomas reach large sizes due to self-neglect and lack of clinical follow-up. Therefore, early diagnosis of endometriomas by providing continuous counseling and keeping a high clinical suspicion might help patients to avoid potential risks of the surgical interventions.

In conclusions, endometriosis can affect women at any age. Although its occurrence is rare in postmenopausal women, it is still quite possible. Endometriomas might reach large sizes regardless their location or patient’s age. Free abdominal endometriomas are a unique manifestation of endometriosis. Its relation with the greater omentum might reflect the presence of previous endometrial implants on the omentum. Endometriosis should be considered as a possible differential diagnosis at any age. Good patient counselling and high clinical suspicion are key factors to diagnose postmenopausal endometriomas before reaching large sizes and provoking potential complications.

Availability of data and materials

All the relevant patient data and clinical history is provided within this article.



Hormone replacement therapy

CT scan:

Computed tomography scan


Prostaglandin E2




Vascular endothelial growth factor


  1. Meuleman C, Vandenabeele B, Fieuws S, Spiessens C, Timmerman D, D'Hooghe T. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril. 2009;92(1):68–74.

    Article  PubMed  Google Scholar 

  2. Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261–75.

    Article  CAS  PubMed  Google Scholar 

  3. Haas D, Chvatal R, Reichert B, Renner S, Shebl O, Binder H, et al. Endometriosis: a premenopausal disease? Age pattern in 42,079 patients with endometriosis. Arch Gynecol Obstet. 2012;286(3):667–70.

    Article  PubMed  Google Scholar 

  4. Nisolle M, Donnez J. Reprint of: Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril. 2019;112(4s1):e125–e36.

    Article  PubMed  Google Scholar 

  5. Lee HJ, Park YM, Jee BC, Kim YB, Suh CS. Various anatomic locations of surgically proven endometriosis: a single-center experience. Obstet Gynecol Sci. 2015;58(1):53–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Riemma G, Schiattarella A, Annona S, La Mantia E, De Franciscis P. An exceptional case of a bloody primary umbilical endometrioma (Villar's Nodule). JOGC. 2019.

  7. Capaccione KM, Levin M, Tchabo N, Darcey J, Amorosa J. Massive endometrioma presenting with dyspnea and abdominal symptoms. Radiol Case Rep. 2017;12(4):741–5.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Sampson JA. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol. 1927;14(4):422–69.

    Article  Google Scholar 

  9. Sakpal SV, Patel C, Chamberlain RS. Near lethal endometriosis and a massive (64 kg) endometrioma: case report and review of the literature. Clin Exp Obstet Gynecol. 2009;36(1):49–52.

    CAS  PubMed  Google Scholar 

  10. La Rosa VL, De Franciscis P, Barra F, Schiattarella A, Török P, Shah M, et al. Quality of life in women with endometriosis: a narrative overview. Minerva Med. 2020;111(1):68–78.

    PubMed  Google Scholar 

  11. La Rosa VL, De Franciscis P, Barra F, Schiattarella A, Tropea A, Tesarik J, et al. Sexuality in women with endometriosis: a critical narrative review. Minerva Med. 2020;111(1):79–89.

    PubMed  Google Scholar 

  12. Attar E, Bulun SE. Aromatase and other steroidogenic genes in endometriosis: translational aspects. Hum Reprod Update. 2006;12(1):49–56.

    Article  CAS  PubMed  Google Scholar 

  13. Streuli I, Gaitzsch H, Wenger JM, Petignat P. Endometriosis after menopause: physiopathology and management of an uncommon condition. Climacteric. 2017;20(2):138–43.

    Article  CAS  PubMed  Google Scholar 

  14. Hulka BS. Links between hormone replacement therapy and neoplasia. Fertil Steril. 1994;62(6 Suppl 2):168S–75S.

    CAS  PubMed  Google Scholar 

  15. Matsushima T, Asakura H. Huge ovarian endometrioma that grew after menopause: case report. J Obstet Gynaecol Res. 2016;42(3):350–2.

    Article  PubMed  Google Scholar 

  16. Takayama K, Zeitoun K, Gunby RT, Sasano H, Carr BR, Bulun SE. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril. 1998;69(4):709–13.

    Article  CAS  PubMed  Google Scholar 

  17. Oral E, Sozen I, Uludag S, Demirkiran F, Ilvan S, Oncul M, et al. The prevalence of endometrioma and associated malignant transformation in women over 40 years of age. J Gynecol Obstet Hum Reprod. 2020;101725.

  18. Noble LS, Takayama K, Zeitoun KM, Putman JM, Johns DA, Hinshelwood MM, et al. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab. 1997;82(2):600–6.

    CAS  PubMed  Google Scholar 

  19. Noble LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J Clin Endocrinol Metab. 1996;81(1):174–9.

    CAS  PubMed  Google Scholar 

  20. Gou Y, Li X, Li P, Zhang H, Xu T, Wang H, et al. Estrogen receptor β upregulates CCL2 via NF-κB signaling in endometriotic stromal cells and recruits macrophages to promote the pathogenesis of endometriosis. Hum Reprod (Oxford, England). 2019;34(4):646–58.

    Article  CAS  Google Scholar 

  21. Laganà AS, Salmeri FM, Ban Frangež H, Ghezzi F, Vrtačnik-Bokal E, Granese R. Evaluation of M1 and M2 macrophages in ovarian endometriomas from women affected by endometriosis at different stages of the disease. Gynecol Endocrinol. 2020;36(5):441–4.

    Article  PubMed  Google Scholar 

  22. Laganà AS, Vitale SG, Salmeri FM, Triolo O, Ban Frangež H, Vrtačnik-Bokal E, et al. Unus pro omnibus, omnes pro uno: a novel, evidence-based, unifying theory for the pathogenesis of endometriosis. Med Hypotheses. 2017;103:10–20.

    Article  PubMed  Google Scholar 

  23. Laganà AS, Garzon S, Götte M, Viganò P, Franchi M, Ghezzi F, et al. The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights. Int J Mol Sci. 2019;20(22):5615.

  24. Tuncay G, Kilic S, Yuksel B, Elmas C, Lortlar N, Erdogan D, et al. Heterogeneous appearance of VEGF (vascular endothelial growth factor) immunopositivity in cyst capsules of endometrioma. Acta Histochem. 2009;111(1):61–7.

    Article  CAS  PubMed  Google Scholar 

  25. Vernon MW, Wilson EA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril. 1985;44(5):684–94.

    Article  CAS  PubMed  Google Scholar 

  26. Jain S, Dalton ME. Chocolate cysts from ovarian follicles. Fertil Steril. 1999;72(5):852–6.

    Article  CAS  PubMed  Google Scholar 

  27. Vercellini P, Somigliana E, Vigano P, Abbiati A, Barbara G, Fedele L. 'Blood on the Tracks' from corpora lutea to endometriomas. BJOG. 2009;116(3):366–71.

    Article  CAS  PubMed  Google Scholar 

  28. Vinatier D, Orazi G, Cosson M, Dufour P. Theories of endometriosis. Eur J Obstet Gynecol Reprod Biol. 2001;96(1):21–34.

    Article  CAS  PubMed  Google Scholar 

  29. Brosens IA, Puttemans P, Deprest J, Rombauts L. The endometriosis cycle and its derailments. Hum Reprod (Oxford, England). 1994;9(5):770–1.

    Article  CAS  Google Scholar 

  30. Zinsser KR, Wheeler JE. Endosalpingiosis in the omentum: a study of autopsy and surgical material. Am J Surg Pathol. 1982;6(2):109–17.

    Article  CAS  PubMed  Google Scholar 

  31. Buy JN, Ghossain MA, Mark AS, Deligne L, Hugol D, Truc JB, et al. Focal hyperdense areas in endometriomas: a characteristic finding on CT. AJR Am J Roentgenol. 1992;159(4):769–71.

    Article  CAS  PubMed  Google Scholar 

  32. Hart RJ, Hickey M, Maouris P, Buckett W. Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev. 2008;(2):Cd.004992.

  33. Vercellini P, Somigliana E, Viganò P, De Matteis S, Barbara G, Fedele L. Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence. Reprod BioMed Online. 2010;21(2):259–65.

    Article  PubMed  Google Scholar 

  34. Polyzos NP, Fatemi HM, Zavos A, Grimbizis G, Kyrou D, Velasco J-G, et al. Aromatase inhibitors in post-menopausal endometriosis. Reprod Biol Endocrinol. 2011;9(1):90.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Słopień R, Męczekalski B. Aromatase inhibitors in the treatment of endometriosis. Przeglad menopauzalny. Menopause Review. 2016;15(1):43–7.

    Article  PubMed  PubMed Central  Google Scholar 

Download references


The authors would like to thank the patient and her family for accepting to share her case with the medical community. The authors are grateful to Dr. Hazem Khout for proof-reading the manuscript and revising the written language.

Competing of interests

All the authors declare that they have no conflicts of interest.


No funding.

Author information

Authors and Affiliations



AN: Reviewed the literature, wrote the article’s abstract, introduction, discussion and conclusions, and wrote the figures’ captions. AS: Reviewed the literature, wrote the case presentation, and revised the manuscript. AA: Led the surgical procedure, followed-up the patient, presented the patient’s information and revised the manuscript. BA: Reviewed the literature, supervised the writing and revised the final version of the manuscript. All the authors read and approved the content of this manuscript.

Corresponding author

Correspondence to Antoine Naem.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Written patient consent was taken before reporting her case.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Naem, A., Shamandi, A., Al-Shiekh, A. et al. Free large sized intra-abdominal endometrioma in a postmenopausal woman: a case report. BMC Women's Health 20, 190 (2020).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: